//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
This is a very big deal, awesome work!
9d
Jonathan Keats, PhD 🇨🇦
A new paper reports identification of a binder of IRF4 and development of a selective degrader that exhibits strong cytotoxicity against multiple myeloma cell lines www.nature.com/articles/s41...
9d
Identification of a binder of interferon regulatory factor 4 (IRF4) enabled development of a selective degrader, dIRF4-2, that exhibited strong cytotoxicity in multiple myeloma cell lines, offering an...
www.nature.com
Pharmacological targeting of IRF4 as a therapeutic strategy for multiple myeloma - Nature Chemical Biology
Nature Chemical Biology